Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
15 participants
INTERVENTIONAL
2023-07-05
2023-12-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Triglyceride Effects on Blood Flow in the Human Brain
NCT05218018
Acute Neuroimmune Effects of Alcohol Using Free Water Imaging
NCT03370783
The Influence of Water and Salt Intake on Copeptin Levels During Moderate Alcohol Consumption
NCT03883503
Beer for Endurance Exercise Recovery
NCT03032445
Effects Ketone Supplement and Alcohol on Brain Metabolism
NCT06815237
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Dehydration and Rehydration Arm
Participants will complete exercise until 5% body mass loss, followed by ad libitum rehydration throughout 2 hours of recovery.
Fluid loss and consumption
Upon 5% body mass loss, rehydration of fluid lost to sweating throughout a 2 hour recovery period
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fluid loss and consumption
Upon 5% body mass loss, rehydration of fluid lost to sweating throughout a 2 hour recovery period
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Recreationally active
* 18-26 years old
Exclusion Criteria
* Hypertensive (systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg) or tachycardic (resting heart rate ≥ 100 bpm) during the screening visit
* Taking medication or supplements with a known side effect of affecting physiological responses to exercise (e.g., aspirin, acetaminophen, beta blockers, statins, stimulants, depressants, SSRIs)
* Tobacco or nicotine use in the past six months
* Current or past musculoskeletal injury impacting physical activity
* Study physician discretion based on any other medical condition or medication
18 Years
26 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
State University of New York at Buffalo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Riana Pryor
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Riana R Pryor, PhD
Role: PRINCIPAL_INVESTIGATOR
University at Buffalo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University at Buffalo
Buffalo, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00007342
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.